我武生物：10月23日召开董事会会议

Group 1 - The company Iwu Biologics (SZ 300357) announced that its 14th meeting of the 5th Board of Directors was held on October 23, 2025, in Shanghai, where it reviewed the proposal to amend the "Audit Committee Work Rules" [1] - For the first half of 2025, the company's revenue composition was 99.59% from pharmaceutical manufacturing and 0.41% from other businesses [1] - As of the report date, Iwu Biologics had a market capitalization of 16.6 billion yuan [1]